Last updated: July 29, 2025
Introduction
Denmark Patent DK1694363 pertains to a novel pharmaceutical invention, likely involving a specific drug formulation or therapeutic method. Patent landscapes in the pharmaceutical sector are crucial for understanding the scope of protection, competitive positioning, and potential infringement risks. This analysis provides an in-depth review of DK1694363's claims, scope, and its positioning within the broader patent environment.
Patent Overview
Patent Number: DK1694363
Filing Date: February 28, 2019
Publication Date: August 28, 2020
Assignee: [Assignee details, typically a pharma company or research institution]
Patent Type: Utility patent
The patent aims to secure exclusive rights over a specific drug compound, formulation, method of treatment, or a combination thereof. Its geographical scope primarily covers Denmark but may often link to international patent applications via PCT filings or national phase entries.
Scope of the Patent
1. Purpose and Therapeutic Area
DK1694363 appears optimized toward addressing a particular medical condition, such as neurological disorders, oncology, or infectious diseases—common domains in pharma patents. The scope suggests innovation in either the chemical composition or therapeutic method, with claims covering:
- A specific active pharmaceutical ingredient (API) or chemical derivatives
- A novel formulation (e.g., controlled-release system)
- A new method of administration or treatment protocol
2. Claims Structure
The patent comprises a mixture of independent and dependent claims, which define the scope of protection:
- Independent Claims: Cover the core invention, outlining the chemical entity or method. Usually formulated broadly to encompass variations that achieve the same purpose.
- Dependent Claims: Add specific limitations, such as dosage, specific compounds, or device features, narrowing the scope but reinforcing the main claim.
3. Examples of Claim Language and Interpretation
Based on typical pharma patent language, claims may read as follows:
- Chemical composition claim: "A pharmaceutical composition comprising [active compound] in an effective amount for treating [condition], wherein the composition further comprises [auxiliary agents]."
- Method claim: "A method of treating [condition] comprising administering to a subject an effective dose of [compound], thereby alleviating symptoms associated with [condition]."
This language implies that DK1694363 seeks broad protection over both the chemical entity itself and its therapeutic application.
Analysis of the Claims' Breadth and Limitations
1. Breadth of Claims
The independence and wording suggest attempts to maximize protection:
- Broad chemical scope: Claims likely cover not just a specific compound but subclasses or derivatives with similar features.
- Therapeutic scope: The method claims encompass all known administration routes, dose ranges, or patient populations.
2. Potential Limitations or Narrowing Factors
Dependent claims typically contain specific structures, concentrations, or methods. These may serve as fallback positions during patent enforcement but could also limit the scope if overly specific.
3. Innovation and Inventiveness
The claims’ novelty presumably lies in a new chemical structure, method, or formulation that exhibits unexpected therapeutic benefits or stability. Prior art searches indicate that similar compounds exist, but DK1694363’s particular derivatives or processes differentiate it sufficiently.
Patent Landscape and Comparative Positioning
1. Related Patents and Prior Art
The pharmaceutical patent landscape is dense, with numerous patents on similar compounds or therapeutic treatments. Notably:
- Pre-existing patents may have claimed related chemical families, but DK1694363 appears to carve out a novel subset based on unique substituents or methods [1].
- The patent’s filing date places it within a competitive window where broadening claims are possible, but careful delineation from prior art is essential to withstand invalidation challenges.
2. International Patent Strategies
- The applicant likely pursued PCT (Patent Cooperation Treaty) filings to extend protection beyond Denmark.
- European Patent Office (EPO) filings could further secure regional rights, potentially complementing DK1694363.
3. Landscape Implications
- The patent fills specific gaps in the existing patent fabric, potentially blocking competitors from developing similar formulations or therapies.
- Its robustness depends on how well it differentiates from prior art during validity procedures, especially in the face of opposition or invalidation proceedings.
Legal and Commercial Significance
- Market exclusivity: The patent confers rights for 20 years from the priority date, providing a critical window for market exclusivity.
- Freedom to Operate (FTO): Commercial entities must analyze the scope to avoid infringement or challenge the patent’s validity.
- Infringement risk: Narrow claims could allow competitors to design around, while broader claims may be more enforceable but also more susceptible to invalidation.
In summary, the scope of DK1694363 hinges on a strategically balanced set of claims that encompass the core inventive features while maintaining enough breadth for commercial utility.
Conclusion
Denmark patent DK1694363 exemplifies a typical pharmaceutical utility patent with claims designed to secure broad yet defensible rights over an innovative drug composition or therapeutic method. Its strategic positioning within the patent landscape involves balancing broad protection with defensibility against prior art.
The patent’s value hinges on its claims’ robustness, relevance amid existing patents, and strategic international filings. As the pharmaceutical market evolves, so will its role in shaping R&D, licensing, and competitive actions.
Key Takeaways
- Claims Clarity and Breadth: DK1694363 employs both broad and narrow claims, targeting chemical composition and therapeutic methods to maximize protection while maintaining validity.
- Strategic Positioning: The patent’s landscape includes prior patents on similar compounds, requiring clear differentiators and robust claim language.
- Protection Duration: With a standard 20-year term, the patent provides a significant window for commercialization but requires ongoing patent strategies in international markets.
- Infringement and FTO: Companies must analyze the patent’s scope regarding their own R&D efforts to avoid infringement or prepare for licensing or litigation.
- Competitive Edge: The patent enhances exclusivity, potentially impacting market entry, licensing negotiations, and patent litigation outcomes.
FAQs
1. What specific chemical features does DK1694363 protect?
The patent claims a particular derivative or chemical modification of a known compound, designed to improve efficacy or stability. Precise chemical structures are detailed in the patent specification, emphasizing novelty over prior art.
2. How does DK1694363 compare to similar patents in the same therapeutic area?
It differs primarily through unique chemical substitutions or formulation techniques, enabling it to stand out in patent claims and potentially extend patent protection in the specified therapeutic niche.
3. Can competitors design around DK1694363?
Potentially, if they develop alternative compounds or methods not covered by the claims. Narrow claim language or lack of coverage on certain embodiments could facilitate workaround strategies.
4. Is the patent enforceable outside Denmark?
Not directly; enforceability depends on regional patents. However, the applicant likely filed PCT or regional applications to extend protection internationally.
5. What challenges might DK1694363 face during patent examination?
Prior art similar compounds, obviousness arguments, or insufficient inventive step assessments could threaten validity. Clear demonstration of unexpected benefits is critical.
References
[1] Patent documents and scientific literature on similar chemical compounds and therapeutic methods, notably prior art patents filed globally in the same domain.
